763 26/6/5 New Pancreatic Cancer Drug Doubles Survival Time, Study Finds

[Lalala11]

1. A new study has foud that a piill called daraxonrasib is helping people with the advanced pancreatic cancer live longer.

2. Researchers at the University of California, Los Amgeles, say the drug blocks a mutated protein that fuels tumor growth in more than 90 percent of pancreatic cancer cases.

3. Dr. Zev Wainberg, who led the study, says the daily pills nearly double survival time, a median of 13.2 months, and with fewer side effects compared to additional chemotherapy.

4. The findings are in The New England Journal of Medicine and were presented Suday at the American Society for Clinical Oncology meeting in Chicago. I'm Donna Warder.